openPR Logo
Press release

Continuous Glucose Monitoring Systems Market - Helps To Manage Diabetes by Providing Real Time Values of the Glucose Levels and Alerts to the Patient In The Event Of Hypo or Hyperglycemia

02-22-2019 10:51 AM CET | Health & Medicine

Press release from: Allied Market Research

Continuous Glucose Monitoring Systems Market

Continuous Glucose Monitoring Systems Market

The Continuous Glucose Monitoring System (CGS) market is expected to reach $ 4,921 million by 2024 and is expected to grow at an annual average rate of 22.9% from 2018 to 2024.

The Continuous Glucose Monitoring System (CGMS) market has emerged as a promising diabetes management tool for monitoring all types of diabetic patients. Replacement / repetitive sales of components such as sensors accelerate the growth of the CGMS market. Continuous glucose monitoring systems are mainly used by patients suffering from hypo and hyperglycemic conditions.

The CGM market has grown significantly due to increased worldwide incidence of diabetes, increased benefits of CGMS devices compared to POC glucometers, increased awareness of developing countries and underdeveloped economies, and technological advances focused on developing CGMS devices I did. However, the absence of proper refund of the device is a major barrier to the adoption of the device.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/1795

The major companies profiled in the report are
• Abbott Laboratories
• Dexcom Inc.
• Menarini Diagnostics
• Echo Therapeutics Inc.
• Insulet Corporation
• GlySens Incorporated
• Johnson & Johnson
• Medtronic plc
• Senseonics Holdings Inc.
• F. Hoffmann-La Roche Ltd.

By component, the sensor generated the highest revenue in 2016, accounting for more than two-thirds of the global continuous blood glucose monitoring system market. According to demographics, the adult population was the highest-earning segment in 2016 and the highest-ever segment of the population.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/1795

Key Findings of the Continuous Glucose Monitoring Systems (CGMS) Market:
• The sensors segment contributed for nearly two-third share of the global continuous glucose monitoring systems market in 2016.
• The integrated insulin pumps segment is projected to grow at a significant CAGR of 17.3% from 2018 to 2023.
• The ICUs segment is projected to grow at a significant CAGR of 22.3% during the forecast period.
• Germany and France are the major shareholders, which collectively accounted for more than one-fourth share of the European continuous glucose monitoring systems market in 2016.
• Japan is the major shareholder, accounting for more than one-fourth share of the Asia-Pacific continuous glucose monitoring systems market in 2016.

Geographical analysis shows, North America and Europe are the most lucrative market segments in the global CGMs market. High purchasing power that renders increased affordability for CGMS devices are the key factors responsible for the growth of this market in Europe and North America.

Asia-Pacific market is expected to grow at a highest CAGR of 29.7% over the analysis period and thus constitutes potential market opportunity for the new market players. Moreover, factors such as rise in the number of patients with diabetes, growth in the purchasing power of the patients and awareness can positively impact the growth of the market in this region.

Access Full Summery @ https://www.alliedmarketresearch.com/global-continuous-glucose-monitoring-systems-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Continuous Glucose Monitoring Systems Market - Helps To Manage Diabetes by Providing Real Time Values of the Glucose Levels and Alerts to the Patient In The Event Of Hypo or Hyperglycemia here

News-ID: 1609731 • Views: 199

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Continuous

Engagedly Introduces Continuous Performance AI SlackBot
Engagedly launches first of its kind, Continuous Performance AI based SlackBot for Slack : Engagedly and Slack join forces to bring collaboration and employee engagement in one place. With Engagedly’s Chatbot, you can now perform various actions in Engagedly while still inside Slack communicating with your colleagues. St. Louis, May 22, 2019 - Engagedly announced today the launch of an AI based Continuous Performance chatbot for Slack that enables employees to
Global Continuous Glucose Monitoring Devices (CGM) Market
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Continuous Glucose Monitoring Device Market. The report analyzes the Global Continuous Glucose Monitoring Market by Component (Transmitter & receiver, sensor, Integrated Insulin Pump), By Demographics (Pediatric, Adult), By End user (Homecare, Hospital), By Region (North America, Europe, Asia Pacific, Rest of the world)
Continuous ‘everything‘ in practice
Moehrendorf, 2 October 2018 – Speed is becoming the key success factor in software development. Continuous integration, delivery and deployment need, however, the corresponding knowledge and the right tools. The Software-QS-Tag 2018 presents both. Also this year the leading conference about software quality assurance and testing in the German-speaking area is accompanied by a technical exhibition. On the whole, 18 associations, service providers, tool suppliers and publishing houses present their solutions
Global Continuous Glucose Monitoring (CGM) Market,
The Global Continuous Glucose Monitoring Market (CGM) was valued at US$ 444.0 million in 2015 and is projected to reach US$ 1,025.2 million by 2024, according to a new report by published by Coherent Market Insights. CGM devices allow monitoring of glucose level during bedtime, noon, pre/post lunch, or before/after exercise, which is a major factor propelling growth of the continuous glucose monitoring market. The global CGM market is undergoing a
Continuous Lifecycle London – Final call for speakers
Calling all CIOs, architects, developers, and ops gurus, speaker proposal submissions need to be in by 30th November 2016 for Continuous Lifecycle London. Continuous Lifecycle London is the conference that hosts the leading thinkers and pioneering users in the Continuous Delivery, containerisation and DevOps community. Additionally, early bird tickets are now on sale and are available until 31st January, for savings of hundreds of pounds. The conference – brought to
Continuous Product Improvement, By Design
The framework provides the principles to design eco-effective solutions using safer materials, which can continue to be cycled back to the technical or biological ecosystems. The first of these uses inorganic or synthetic man-made nutrients that can be used many times without loss of quality. The biological ecosystem uses materials that can decompose into the natural environment, without causing any damage to it. Biological and Technological Ecosystems Driving change across the whole